Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-068281
Filing Date
2025-05-09
Accepted
2025-05-09 17:30:35
Documents
1
Period of Report
2025-05-07

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5913
  Complete submission text file 0000950170-25-068281.txt   7306
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Issuer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O HCW BIOLOGICS, INC. 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address
Byam Rebecca (Reporting) CIK: 0001866256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40591 | Film No.: 25931863